LMR Partners’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-158,249
| Closed | -$517K | – | 882 |
|
|
2024
Q4 | $517K | Sell |
158,249
-38,776
| -20% | -$127K | ﹤0.01% | 470 |
|
|
2024
Q3 | $759K | Sell |
197,025
-58,376
| -23% | -$225K | 0.01% | 353 |
|
|
2024
Q2 | $789K | Buy |
255,401
+195,401
| +326% | +$604K | 0.01% | 349 |
|
|
2024
Q1 | $155K | Hold |
60,000
| – | – | ﹤0.01% | 478 |
|
|
2023
Q4 | $150K | Buy |
60,000
+2,667
| +5% | +$6.67K | ﹤0.01% | 431 |
|
|
2023
Q3 | $116K | Hold |
57,333
| – | – | ﹤0.01% | 469 |
|
|
2023
Q2 | $132K | Sell |
57,333
-2,667
| -4% | -$6.13K | ﹤0.01% | 488 |
|
|
2023
Q1 | $182K | Hold |
60,000
| – | – | ﹤0.01% | 853 |
|
|
2022
Q4 | $140K | Buy |
60,000
+6,060
| +11% | +$14.1K | ﹤0.01% | 1008 |
|
|
2022
Q3 | $103K | Hold |
53,940
| – | – | ﹤0.01% | 1035 |
|
|
2022
Q2 | $146K | Sell |
53,940
-6,060
| -10% | -$16.4K | ﹤0.01% | 1079 |
|
|
2022
Q1 | $179K | Hold |
60,000
| – | – | ﹤0.01% | 1148 |
|
|
2021
Q4 | $233K | Buy |
+60,000
| New | +$233K | ﹤0.01% | 1046 |
|
|
2021
Q2 | – | Sell |
-42,171
| Closed | -$140K | – | 1085 |
|
|
2021
Q1 | $140K | Sell |
42,171
-60,594
| -59% | -$201K | ﹤0.01% | 824 |
|
|
2020
Q4 | $365K | Sell |
102,765
-5,147
| -5% | -$18.3K | 0.01% | 370 |
|
|
2020
Q3 | $338K | Hold |
107,912
| – | – | 0.01% | 303 |
|
|
2020
Q2 | $196K | Buy |
+107,912
| New | +$196K | ﹤0.01% | 489 |
|
|
2019
Q4 | – | Sell |
-29,104
| Closed | -$44K | – | 389 |
|
|
2019
Q3 | $44K | Hold |
29,104
| – | – | ﹤0.01% | 380 |
|
|
2019
Q2 | $61K | Buy |
+29,104
| New | +$61K | ﹤0.01% | 372 |
|
|
2014
Q4 | – | Sell |
-15,895
| Closed | -$337K | – | 359 |
|
|
2014
Q3 | $337K | Buy |
+15,895
| New | +$337K | 0.03% | 207 |
|
|
2014
Q2 | – | Sell |
-15,178
| Closed | -$329K | – | 455 |
|
|
2014
Q1 | $329K | Buy |
+15,178
| New | +$329K | 0.05% | 176 |
|